NBE-Therapeutics Revenue

Biotechnology Research • Basel, Basel, Switzerland • 21-50 Employees

NBE-Therapeutics revenue & valuation

Annual revenue	$9,600,000
Revenue per employee	$200,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$30,800,000
Total funding	$22,000,000

Key Contact at NBE-Therapeutics

Ulrike Fiedler

Senior Director Program Management And Pipeline Innovation

Company overview

Headquarters	Hochbergstrasse 60C, Technology Park Basel AG, Basel, 4057, CH
Phone number	+41616332230
Website	nbe-therapeutics.com
NAICS	541714
SIC	283
Employees	21-50
Socials

NBE-Therapeutics Email Formats

NBE-Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@nbe-therapeutics.com), used 63.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@nbe-therapeutics.com	63.6%
{first name}.{last name}	john.doe@nbe-therapeutics.com	36.4%

About NBE-Therapeutics

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Head

Manager

Employees by Department

NBE-Therapeutics has 20 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore NBE-Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-02-10	6	$22,000,000

Funding Insights

$22,000,000

Total funding amount

$22,000,000

Most recent funding amount

Number of funding rounds

NBE-Therapeutics Tech Stack

Discover the technologies and tools that power NBE-Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Tag Manager

Tag managers

Cookiebot

Cookie compliance

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

Yii

Web frameworks

Cookie Control

Cookie compliance

lit-element

JavaScript libraries

Google Analytics

Analytics

Google Maps

Maps

LazySizes

JavaScript libraries

Craft CMS

CMS

Frequently asked questions

NBE-Therapeutics is located in Basel, Basel, CH.

You can reach NBE-Therapeutics at +41616332230.

NBE-Therapeutics generates an estimated annual revenue of $9,600,000. This revenue figure reflects the company's market position and business performance in its industry.

NBE-Therapeutics has an estimated valuation of $30,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NBE-Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

NBE-Therapeutics has raised a total of $22,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at NBE-Therapeutics

Ulrike Fiedler

Senior Director Program Management And Pipeline Innovation

4.8

40,000 users